<h4>Background & aims</h4>Quantification of the human S100A8/S100A9 tetrameric protein complex in stool, referred to as fecal calprotectin, is an extensively validated biomarker supporting the diagnosis and management of gastrointestinal diseases. The gene discussed is S100A9; the disease is gastrointestinal disease.